Why Non-Sintered Calcium Phosphate Changes the Game for Bone Grafts
When it comes to bone graft materials, not all calcium phosphates work the same way. Many rely on sintering, a high-heat process that can lock ions in place, reduces porosity, and creates a dense ceramic structure. While this manufacturing approach creates a stable material, it comes at a clinical cost: the material may lose some of its bioactivity. OsteoGen™ takes a completely different approach.
The Bioactive Advantage
As a non-sintered calcium phosphate, OsteoGen™ retains the bioactive properties that sintering can affect. This distinction matters clinically because bioactivity is what allows active participation in bone regeneration.
Bioactivity enables OsteoGen™ crystals to exchange ions with their surrounding environment. As the material is exposed to the biological fluids of the surgical site, it releases calcium, phosphate, and hydroxyl ions. These ions don't just sit passively, rather, they actively interact with local cells and influence the healing microenvironment. Rather than serving only as a structural graft material, OsteoGen™ interacts with the body’s biology through ion exchange to support natural regenerative processes.
How Ion Exchange Supports Healing
This ion exchange creates conditions that encourage osteoblast recruitment, proliferation, and maturation. The body recognizes OsteoGen™ as a biocompatible material and breaks it down readily, as it is replaced with vital bone, minimizing encapsulation in connective tissue.
Sintered materials, by contrast, can resist this natural resorption process, often remaining partially unincorporated months after placement.
What This Means for Your Practice
For clinicians, this translates to a graft material that supports more predictable new bone growth. For patients, it means a biological foundation built for lasting results and reliable implant outcomes.
By preserving bioactivity, OsteoGen™ sets the stage for strong regenerative outcomes—the kind that gives you confidence in both immediate and long-term implant success.
|
